Bronchodilator effect on O2 deficit and V'O2 kinetics during moderate intensity exercise in normoxemic COPD [chronic obstructive pulmonary disease]
Phase of Trial: Phase II
Latest Information Update: 28 Apr 2011
At a glance
- Drugs Ipratropium-bromide/salbutamol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 18 Apr 2011 Status changed from recruiting to completed, according to ClinicalTrials.gov.
- 22 Sep 2006 New trial record.